Drug intelligence / Profile preview

PMS Gummy

Development stage: Preclinical
Lead developer: Semaine Health
Administration: Oral

Overview

PMS Gummy is a dietary supplement in gummy form being evaluated for its effectiveness in alleviating premenstrual syndrome symptoms. It is currently undergoing a virtual, randomized, placebo-controlled clinical trial sponsored by Semaine Health. Participants in the trial take 2 gummies, 4 times daily, starting at the onset of PMS symptoms and continuing until symptoms subside.

Beyond the preview

Go deeper on PMS Gummy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PMS Gummy.

Explore the full profile